The Vanguard Group 13D/13G Filings for Mirum Pharmaceuticals, Inc. (MIRM)

The Vanguard Group 13D and 13G filings for Mirum Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-13
5:09 pm
Purchase
2023-12-29 13G Mirum Pharmaceuticals, Inc.
MIRM
The Vanguard Group 2,476,244
5.310%
2,476,244increase
(New Position)
Filing